Cargando…
The DARC Side of Inflamm-Aging: Duffy Antigen Receptor for Chemokines (DARC/ACKR1) as a Potential Biomarker of Aging, Immunosenescence, and Breast Oncogenesis among High-Risk Subpopulations
The proclivity of certain pre-malignant and pre-invasive breast lesions to progress while others do not continues to perplex clinicians. Clinicians remain at a crossroads with effectively managing the high-risk patient subpopulation owing to the paucity of biomarkers that can adequately risk-stratif...
Autores principales: | Jinna, Nikita, Rida, Padmashree, Su, Tianyi, Gong, Zhihong, Yao, Song, LaBarge, Mark, Natarajan, Rama, Jovanovic-Talisman, Tijana, Ambrosone, Christine, Seewaldt, Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740232/ https://www.ncbi.nlm.nih.gov/pubmed/36497078 http://dx.doi.org/10.3390/cells11233818 |
Ejemplares similares
-
The Duffy Antigen Receptor for Chemokines DARC/ACKR1
por: Horuk, Richard
Publicado: (2015) -
Adaptation to Hypoxia May Promote Therapeutic Resistance to Androgen Receptor Inhibition in Triple-Negative Breast Cancer
por: Jinna, Nikita, et al.
Publicado: (2022) -
Racial Disparity in Quadruple Negative Breast Cancer: Aggressive Biology and Potential Therapeutic Targeting and Prevention
por: Jinna, Nikita, et al.
Publicado: (2022) -
An introduction to DARC technology
por: Ahmad, Syed Shoeb
Publicado: (2017) -
Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean
por: Grann, Victor R, et al.
Publicado: (2008)